And just for a change here we go another week ending with the same usual disgraceful results. Is this the kind incentive expected after the free granted options to themselves.
Management must be really proud of their work/result.
- Forums
- ASX - By Stock
- PER
- Ann: Phase IIb study of ATL1102 in DMD completes recruitment
PER
percheron therapeutics limited
Add to My Watchlist
11.1%
!
1.0¢

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-128
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $10.87M |
Open | High | Low | Value | Volume |
0.9¢ | 1.0¢ | 0.9¢ | $8.495K | 918.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1277347 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 1853198 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1277347 | 0.009 |
6 | 3248000 | 0.008 |
3 | 1282857 | 0.007 |
1 | 1000000 | 0.006 |
3 | 4199997 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 1853198 | 6 |
0.011 | 842858 | 6 |
0.012 | 2658324 | 5 |
0.013 | 691461 | 3 |
0.014 | 1572000 | 3 |
Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |